Eventide Asset Management, LLC Kala Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $17.5 Million - $28.1 Million	-3,450,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $4.14 Million - $6.86 Million	497,101 Added 16.83%	3,450,000 $36.3 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $11.3 Million - $26 Million	2,952,899 New	2,952,899 $26 Million
Q4 2017 Feb 14, 2018	SELL	$13.68 - $23.17 $820,800 - $1.39 Million	-60,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $1.19 Million - $1.59 Million	60,000	60,000 $1.37 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.25M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.